new

Get trending papers in your email inbox!

Subscribe

byAK and the research community

Mar 14

Reward Guided Latent Consistency Distillation

Latent Consistency Distillation (LCD) has emerged as a promising paradigm for efficient text-to-image synthesis. By distilling a latent consistency model (LCM) from a pre-trained teacher latent diffusion model (LDM), LCD facilitates the generation of high-fidelity images within merely 2 to 4 inference steps. However, the LCM's efficient inference is obtained at the cost of the sample quality. In this paper, we propose compensating the quality loss by aligning LCM's output with human preference during training. Specifically, we introduce Reward Guided LCD (RG-LCD), which integrates feedback from a reward model (RM) into the LCD process by augmenting the original LCD loss with the objective of maximizing the reward associated with LCM's single-step generation. As validated through human evaluation, when trained with the feedback of a good RM, the 2-step generations from our RG-LCM are favored by humans over the 50-step DDIM samples from the teacher LDM, representing a 25 times inference acceleration without quality loss. As directly optimizing towards differentiable RMs can suffer from over-optimization, we overcome this difficulty by proposing the use of a latent proxy RM (LRM). This novel component serves as an intermediary, connecting our LCM with the RM. Empirically, we demonstrate that incorporating the LRM into our RG-LCD successfully avoids high-frequency noise in the generated images, contributing to both improved FID on MS-COCO and a higher HPSv2.1 score on HPSv2's test set, surpassing those achieved by the baseline LCM.

A SARS-CoV-2 Interaction Dataset and VHH Sequence Corpus for Antibody Language Models

Antibodies are crucial proteins produced by the immune system to eliminate harmful foreign substances and have become pivotal therapeutic agents for treating human diseases. To accelerate the discovery of antibody therapeutics, there is growing interest in constructing language models using antibody sequences. However, the applicability of pre-trained language models for antibody discovery has not been thoroughly evaluated due to the scarcity of labeled datasets. To overcome these limitations, we introduce AVIDa-SARS-CoV-2, a dataset featuring the antigen-variable domain of heavy chain of heavy chain antibody (VHH) interactions obtained from two alpacas immunized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike proteins. AVIDa-SARS-CoV-2 includes binary labels indicating the binding or non-binding of diverse VHH sequences to 12 SARS-CoV-2 mutants, such as the Delta and Omicron variants. Furthermore, we release VHHCorpus-2M, a pre-training dataset for antibody language models, containing over two million VHH sequences. We report benchmark results for predicting SARS-CoV-2-VHH binding using VHHBERT pre-trained on VHHCorpus-2M and existing general protein and antibody-specific pre-trained language models. These results confirm that AVIDa-SARS-CoV-2 provides valuable benchmarks for evaluating the representation capabilities of antibody language models for binding prediction, thereby facilitating the development of AI-driven antibody discovery. The datasets are available at https://datasets.cognanous.com.

AVIDa-hIL6: A Large-Scale VHH Dataset Produced from an Immunized Alpaca for Predicting Antigen-Antibody Interactions

Antibodies have become an important class of therapeutic agents to treat human diseases. To accelerate therapeutic antibody discovery, computational methods, especially machine learning, have attracted considerable interest for predicting specific interactions between antibody candidates and target antigens such as viruses and bacteria. However, the publicly available datasets in existing works have notable limitations, such as small sizes and the lack of non-binding samples and exact amino acid sequences. To overcome these limitations, we have developed AVIDa-hIL6, a large-scale dataset for predicting antigen-antibody interactions in the variable domain of heavy chain of heavy chain antibodies (VHHs), produced from an alpaca immunized with the human interleukin-6 (IL-6) protein, as antigens. By leveraging the simple structure of VHHs, which facilitates identification of full-length amino acid sequences by DNA sequencing technology, AVIDa-hIL6 contains 573,891 antigen-VHH pairs with amino acid sequences. All the antigen-VHH pairs have reliable labels for binding or non-binding, as generated by a novel labeling method. Furthermore, via introduction of artificial mutations, AVIDa-hIL6 contains 30 different mutants in addition to wild-type IL-6 protein. This characteristic provides opportunities to develop machine learning models for predicting changes in antibody binding by antigen mutations. We report experimental benchmark results on AVIDa-hIL6 by using neural network-based baseline models. The results indicate that the existing models have potential, but further research is needed to generalize them to predict effective antibodies against unknown mutants. The dataset is available at https://avida-hil6.cognanous.com.